Trends in costs of percutaneous transluminal coronary angioplasty

American Journal of Managed Care

Volumn 4, Issue 12, 1998, Pages 1667-1674

  Heiat, Asefeh ^a   Mattera, Jennifer A ^a   Henry, Glen A ^c   Chen, Ya Ting ^a   Krumholz, Harlan M ^a,b,c  

^a YALE NEW HAVEN HOSPITAL   (United States)

^b Dept of Epidemiol and Pub Health ^*  (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACCOUNTING; ADULT; AGED; ARTICLE; CINEANGIOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEALTH CARE COST; HEART CATHETERIZATION; HOSPITAL COST; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MANAGED CARE; PRIORITY JOURNAL; RESOURCE ALLOCATION; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CONNECTICUT; COST CONTROL; DATA COLLECTION; FEMALE; HOSPITAL COSTS; HOSPITALS, UNIVERSITY; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); RETROSPECTIVE STUDIES; TECHNOLOGY ASSESSMENT, BIOMEDICAL; UTILIZATION REVIEW;

EID: 0032410844     PISSN: 10880224     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Sukin CA, Baim DS, Caputo RP, et al. The impact of optimal stenting techniques on cardiac catheterization laboratory resource utilization and costs. Am J Cardiol 1997; 79:275-280.
2. Cohen DJ, Krumholz HM, Sukin CA, et al. In-hospital and one-year economic outcomes after coronary stenting or balloon angioplasty. Results from a randomized clinical trial. Stent Restenosis Study Investigators. Circulation 1995; 92:2480-2487.
3. Sculpher MJ, Seed P, Henderson RA, et al. Health service costs of coronary angioplasty and coronary artery bypass surgery: The Randomised Intervention Treatment of Angina (RITA) trial. Lancet 1994;344:927-930.
4. Cohen DJ, Breall JA, Ho KK, et al. Evaluating the potential cost-effectiveness of stenting as a treatment for symptomatic single-vessel coronary disease. Use of a decision-analytic model. Circulation 1994;89:1859-1874.
5. Cohen DJ, Breall JA, Ho KK, et al. Economics of elective coronary revascularization. Comparison of costs and charges for conventional angioplasty, directional atherectomy, stenting and bypass surgery. J Am Coll Cardiol 1993;22: 1052-1059.
6. Guidelines for percutaneous transluminal coronary angioplasty. A report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Subcommittee on Percutaneous Transluminal Coronary Angioplasty). J Am Coll Cardiol 1988;12:529-545.
7. Fischman DL, Savage MP, Leon MB, et al. Effect of intracoronary stenting on intimal dissection after balloon angioplasty: Results of quantitative and qualitative coronary analysis. J Am Coll Cardiol 1991;18:1445-1451.
8. Fischman DL, Leon MB, Baim DS, et al. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators. N Engl J Med 1994; 331:496-501.
9. Serruys PW, de Jaegere P, Kiemeneij F, et al. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group. N Engl J Med 1994;331:489-495.
10. Laham RJ, Carrozza JP, Berger C, Cohen DJ, Kuntz RE, Baim DS. Long-term (4-to 6-year) outcome of Palmaz-Schatz stenting: Paucity of late clinical stent-related problems. J Am Coll Cardiol 1996;28:820-826.
11. Thompson RC, Holmes DR, Jr., Grill DE, Mock MB, Bailey KR. Changing outcome of angioplasty in the elderly. J Am Coll Cardiol 1996;27:8-14.
12. Fitzgerald ST, Merrill A, Aversano T, Sorkin A. Direct and indirect cost of percutaneous transluminal coronary angioplasty. Cardiology 1994;85:298-302.
13. O'Murchu B, Gersh BJ, Reeder GS, Bailey KR, Holmes DR, Jr. Late outcome after percutaneous transluminal coronary angioplasty during acute myocardial infarction. Am J Cardiol 1993;72:634-639.
14. Topol EJ, Leya F, Pinkerton CA, et al. A comparison of directional atherectomy with coronary angioplasty in patients with coronary artery disease. The CAVEAT Study Group. N Engl J Med 1993;329:221-227.
15. Guzman LA, Simpfendorfer C, Fix J, Franco I, Whitlow PL. Comparison of costs of new atherectomy devices and balloon angioplasty for coronary artery disease. Am J Cardiol 1994;74:22-25.
16. de Boer MJ, van Hout BA, Liem AL, Suryapranata H, Hoorntje JC, Zijlstra F. A cost-effective analysis of primary coronary angioplasty versus thrombolysis for acute myocardial infarction. Am J Cardiol 1995;76:830-833.
17. Zijlstra F, de Boer MJ, Beukema WP, et al. Mortality, reinfarction, left ventricular ejection fraction and costs following reperfusion therapies for acute myocardial infarction. Eur Heart J 1996;17:382-387.
18. Goods CM, Liu MW, Iyer SS, et al. A cost analysis of coronary stenting without anticoagulation versus stenting with anticoagulation using warfarin. Am J Cardiol 1996; 78:334-336.
19. Califf RM, Lincoff AM, Tcheng JE, Topol EJ. An overview of the results of the EPIC trial. Eur Heart J 1995;16:43-49.
20. Topol EJ, Ferguson JJ, Weisman HF, et al. Long-term protection from myocardial ischemic events in a randomized trial of brief integrin ß3 blockade with percutaneous coronary intervention. EPIC Investigator Group. Evaluation of Platelet IIb/IIIa Inhibition for Prevention of Ischemic Complication. JAMA 1997;278:479-484.